Wandercraft Seeks €100M at €750M Valuation

This funding round signals growing investor confidence in medical robotics, where hardware-heavy startups require deep capital for regulatory and market entry. The valuation implies a bet on the scalability of exoskeleton technology beyond niche rehab settings, likely targeting broader mobility assistance. For the sector, it highlights how European deep-tech firms are securing sizable late-stage rounds, potentially easing future capital access for peers. The key watchpoint is whether Wandercraft can convert this capital into tangible commercial traction and regulatory wins, as execution risk remains high in this space.